Susquehanna International Group, LLP Esperion Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.61 - $2.73 $1.13 Million - $1.92 Million	-702,800 Reduced 75.18%	232,000 $382,000
Q2 2024 Aug 15, 2024	BUY	$1.84 - $3.24 $609,224 - $1.07 Million	331,100 Added 54.85%	934,800 $2.08 Million
Q1 2024 May 07, 2024	BUY	$2.02 - $3.02 $991,012 - $1.48 Million	490,600 Added 433.78%	603,700 $1.62 Million
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $155,344 - $655,424	-212,800 Reduced 65.3%	113,100 $338,000
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $5,184 - $9,666	-5,400 Reduced 1.63%	325,900 $319,000
Q2 2023 Aug 11, 2023	SELL	$1.2 - $1.76 $11,520 - $16,896	-9,600 Reduced 2.82%	331,300 $460,000
Q1 2023 May 16, 2023	SELL	$1.46 - $7.3 $363,978 - $1.82 Million	-249,300 Reduced 42.24%	340,900 $542,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $776,225 - $1.3 Million	152,500 Added 34.84%	590,200 $3.68 Million
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $391,855 - $584,547	-71,900 Reduced 14.11%	437,700 $2.93 Million
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $1.38 Million - $1.93 Million	290,100 Added 132.16%	509,600 $3.24 Million
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $177,020 - $294,680	53,000 Added 31.83%	219,500 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $790,282 - $1.96 Million	-164,300 Reduced 49.67%	166,500 $833,000
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $2.38 Million - $4.49 Million	210,100 Added 174.07%	330,800 $3.99 Million
Q2 2021 Aug 11, 2021	BUY	$19.4 - $28.71 $1.39 Million - $2.06 Million	71,600 Added 145.82%	120,700 $2.55 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $936,976 - $1.38 Million	-37,300 Reduced 43.17%	49,100 $1.38 Million
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $3.5 Million - $5.17 Million	-144,600 Reduced 62.6%	86,400 $2.25 Million
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $4.43 Million - $7.49 Million	142,100 Added 159.84%	231,000 $8.59 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $1.57 Million - $2.68 Million	52,200 Added 142.23%	88,900 $4.56 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $2.7 Million - $7.27 Million	-98,500 Reduced 72.86%	36,700 $1.16 Million
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $1.54 Million - $2.61 Million	-43,600 Reduced 24.38%	135,200 $8.06 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $1.38 Million - $1.9 Million	39,900 Added 28.73%	178,800 $6.56 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $4.19 Million - $5.47 Million	104,500 Added 303.78%	138,900 $6.46 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $3.97 Million - $5.3 Million	-98,900 Reduced 74.19%	34,400 $1.38 Million
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $8.01 Million - $12.8 Million	-216,600 Reduced 61.9%	133,300 $6.13 Million
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $10.1 Million - $12.7 Million	247,800 Added 242.7%	349,900 $15.5 Million
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $18.6 Million - $39.3 Million	-514,700 Reduced 83.45%	102,100 $4 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $30 Million - $36.8 Million	455,200 Added 281.68%	616,800 $44.6 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $2.5 Million - $3.87 Million	57,400 Added 55.09%	161,600 $10.6 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $4.56 Million - $5.5 Million	104,200	104,200 $5.22 Million

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account